These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24098664)

  • 1. Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.
    Rooney J; Byrne S; Heverin M; Corr B; Elamin M; Staines A; Goldacre B; Hardiman O
    PLoS One; 2013; 8(9):e74733. PubMed ID: 24098664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of geospatial factors in the Irish ALS cohort.
    Rooney J; Heverin M; Vajda A; Burke T; Galvin M; Tobin K; Elamin M; Staines A; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):555-560. PubMed ID: 27145090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021.
    McFarlane R; Peelo C; Galvin M; Heverin M; Hardiman O
    Neurology; 2023 Nov; 101(19):e1905-e1912. PubMed ID: 37748881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival.
    Miladinovic B; Kumar A; Mhaskar R; Kim S; Schonwetter R; Djulbegovic B
    PLoS One; 2012; 7(10):e47804. PubMed ID: 23082220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current application of the Royston-Parmar model for prognostic modeling in health research: a scoping review.
    Ng R; Kornas K; Sutradhar R; Wodchis WP; Rosella LC
    Diagn Progn Res; 2018; 2():4. PubMed ID: 31093554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis.
    Liu T; Shen D; Yang X; Cui B; Tai H; Wang Z; Liu S; Zhang K; Liu M; Cui L
    J Clin Neurosci; 2019 Nov; 69():74-80. PubMed ID: 31447367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Royston-Parmar flexible parametric survival model to predict the probability of keratoconus progression to corneal transplantation.
    Quartilho A; Gore DM; Bunce C; Tuft SJ
    Eye (Lond); 2020 Apr; 34(4):657-662. PubMed ID: 31462761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.
    O'Toole O; Traynor BJ; Brennan P; Sheehan C; Frost E; Corr B; Hardiman O
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):30-2. PubMed ID: 17634215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study.
    Luna J; Diagana M; Ait Aissa L; Tazir M; Ali Pacha L; Kacem I; Gouider R; Henning F; Basse A; Cisse O; Balogou AAK; Kombate D; Agbetou M; Houinato D; Millogo A; Agba T; Belo M; Penoty M; Raymondeau-Moustafa M; Hamidou B; Couratier P; Preux PM; Marin B;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):20-29. PubMed ID: 30242088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictors of survival in Chinese amyotrophic lateral sclerosis patients.
    Wei Q; Chen X; Zheng Z; Guo X; Huang R; Cao B; Zeng Y; Shang H
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):237-44. PubMed ID: 25581512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register).
    Luna J; Defressigne O; Erazo D; Lautrette G; Raymondeau-Moustafa M; Preux PM; Boumediene F; Couratier P
    Rev Neurol (Paris); 2022 Nov; 178(9):914-923. PubMed ID: 36163089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center.
    Klavžar P; Koritnik B; Leonardis L; Dolenc Grošelj L; Kirbiš M; Ristić Kovačič S; Klinar P; Pohar Perme M; Zidar J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):203-208. PubMed ID: 32248716
    [No Abstract]   [Full Text] [Related]  

  • 17. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease.
    Forbes RB; Colville S; Cran GW; Swingler RJ;
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1753-5. PubMed ID: 15548498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
    Haverkamp LJ; Appel V; Appel SH
    Brain; 1995 Jun; 118 ( Pt 3)():707-19. PubMed ID: 7600088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1258-61. PubMed ID: 12933930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.